Global Opioid-induced Constipation Market Research Report 2018

Published: Nov, 2018 | Pages: 126 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)


This report studies the global Opioid-induced Constipation market status and forecast, categorizes the global Opioid-induced Constipation market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report 
    AstraZeneca
    Takeda Pharmaceutical
    Valeant Pharmaceuticals International
    Abbott
    Bayer
    Boehringer Ingelheim
    C.B. Fleet
    Cosmo Pharmaceuticals
    Daewoong
    Daiichi Sankyo
    GlaxoSmithKline
    Ironwood Pharmaceuticals
    Johnson & Johnson
    Merck
    Mundipharma
    Nektar Therapeutics
    Pfizer
    Progenics Pharmaceuticals
    Shionogi
    SLA Pharma
    Sucampo
    Synergy Pharmaceuticals
    Theravance��

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Solid
    Liquid
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Drugstore
    Hospital
    Others

The study objectives of this report are:
    To analyze and study the global Opioid-induced Constipation capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
    Focuses on the key Opioid-induced Constipation manufacturers, to study the capacity, production, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Opioid-induced Constipation are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Opioid-induced Constipation Manufacturers
Opioid-induced Constipation Distributors/Traders/Wholesalers
Opioid-induced Constipation Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Opioid-induced Constipation market, by end-use.
Detailed analysis and profiles of additional market players.

 Table of Contents

Global Opioid-induced Constipation Market Research Report 2018
1 Opioid-induced Constipation Market Overview
    1.1 Product Overview and Scope of Opioid-induced Constipation
    1.2 Opioid-induced Constipation Segment by Type (Product Category)
        1.2.1 Global Opioid-induced Constipation Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        1.2.2 Global Opioid-induced Constipation Production Market Share by Type (Product Category) in 2017
        1.2.3 Solid
        1.2.3 Liquid
    1.3 Global Opioid-induced Constipation Segment by Application
        1.3.1 Opioid-induced Constipation Consumption (Sales) Comparison by Application (2013-2025)
        1.3.2 Drugstore
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Opioid-induced Constipation Market by Region (2013-2025)
        1.4.1 Global Opioid-induced Constipation Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        1.4.2 North America Status and Prospect (2013-2025)
        1.4.3 Europe Status and Prospect (2013-2025)
        1.4.4 China Status and Prospect (2013-2025)
        1.4.5 Japan Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Status and Prospect (2013-2025)
        1.4.7 India Status and Prospect (2013-2025)
    1.5 Global Market Size (Value) of Opioid-induced Constipation (2013-2025)
        1.5.1 Global Opioid-induced Constipation Revenue Status and Outlook (2013-2025)
        1.5.2 Global Opioid-induced Constipation Capacity, Production Status and Outlook (2013-2025)

2 Global Opioid-induced Constipation Market Competition by Manufacturers
    2.1 Global Opioid-induced Constipation Capacity, Production and Share by Manufacturers (2013-2018)
        2.1.1 Global Opioid-induced Constipation Capacity and Share by Manufacturers (2013-2018)
        2.1.2 Global Opioid-induced Constipation Production and Share by Manufacturers (2013-2018)
    2.2 Global Opioid-induced Constipation Revenue and Share by Manufacturers (2013-2018)
    2.3 Global Opioid-induced Constipation Average Price by Manufacturers (2013-2018)
    2.4 Manufacturers Opioid-induced Constipation Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Opioid-induced Constipation Market Competitive Situation and Trends
        2.5.1 Opioid-induced Constipation Market Concentration Rate
        2.5.2 Opioid-induced Constipation Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Opioid-induced Constipation Capacity, Production, Revenue (Value) by Region (2013-2018)
    3.1 Global Opioid-induced Constipation Capacity and Market Share by Region (2013-2018)
    3.2 Global Opioid-induced Constipation Production and Market Share by Region (2013-2018)
    3.3 Global Opioid-induced Constipation Revenue (Value) and Market Share by Region (2013-2018)
    3.4 Global Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.5 North America Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.6 Europe Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.7 China Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.8 Japan Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.9 Southeast Asia Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.10 India Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Opioid-induced Constipation Supply (Production), Consumption, Export, Import by Region (2013-2018)
    4.1 Global Opioid-induced Constipation Consumption by Region (2013-2018)
    4.2 North America Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
    4.3 Europe Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
    4.4 China Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
    4.5 Japan Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
    4.6 Southeast Asia Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)
    4.7 India Opioid-induced Constipation Production, Consumption, Export, Import (2013-2018)

5 Global Opioid-induced Constipation Production, Revenue (Value), Price Trend by Type
    5.1 Global Opioid-induced Constipation Production and Market Share by Type (2013-2018)
    5.2 Global Opioid-induced Constipation Revenue and Market Share by Type (2013-2018)
    5.3 Global Opioid-induced Constipation Price by Type (2013-2018)
    5.4 Global Opioid-induced Constipation Production Growth by Type (2013-2018)

6 Global Opioid-induced Constipation Market Analysis by Application
    6.1 Global Opioid-induced Constipation Consumption and Market Share by Application (2013-2018)
    6.2 Global Opioid-induced Constipation Consumption Growth Rate by Application (2013-2018)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Opioid-induced Constipation Manufacturers Profiles/Analysis
    7.1 AstraZeneca
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Opioid-induced Constipation Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AstraZeneca Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.1.4 Main Business/Business Overview
    7.2 Takeda Pharmaceutical
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Opioid-induced Constipation Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Takeda Pharmaceutical Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.2.4 Main Business/Business Overview
    7.3 Valeant Pharmaceuticals International
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Opioid-induced Constipation Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Valeant Pharmaceuticals International Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.3.4 Main Business/Business Overview
    7.4 Abbott
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Opioid-induced Constipation Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Abbott Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.4.4 Main Business/Business Overview
    7.5 Bayer
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Opioid-induced Constipation Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Bayer Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        7.5.4 Main Business/Business Overview
    7.6 Boehringer Ingelheim
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Opioid-induced Constipation Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Boehringer Ingelheim Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.6.4 Main Business/Business Overview
    7.7 C.B. Fleet
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Opioid-induced Constipation Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 C.B. Fleet Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.7.4 Main Business/Business Overview
    7.8 Cosmo Pharmaceuticals
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Opioid-induced Constipation Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Cosmo Pharmaceuticals Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.8.4 Main Business/Business Overview
    7.9 Daewoong
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Opioid-induced Constipation Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Daewoong Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.9.4 Main Business/Business Overview
    7.8 Daiichi Sankyo
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Opioid-induced Constipation Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Daiichi Sankyo Opioid-induced Constipation Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        7.10.4 Main Business/Business Overview
    7.11 GlaxoSmithKline
    7.12 Ironwood Pharmaceuticals
    7.13 Johnson & Johnson
    7.14 Merck
    7.15 Mundipharma
    7.16 Nektar Therapeutics
    7.17 Pfizer
    7.18 Progenics Pharmaceuticals
    7.19 Shionogi
    7.20 SLA Pharma
    7.21 Sucampo
    7.22 Synergy Pharmaceuticals
    7.23 Theravance  

8 Opioid-induced Constipation Manufacturing Cost Analysis
    8.1 Opioid-induced Constipation Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Opioid-induced Constipation

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Opioid-induced Constipation Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Opioid-induced Constipation Major Manufacturers in 2017
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Opioid-induced Constipation Market Forecast (2018-2025)
    12.1 Global Opioid-induced Constipation Capacity, Production, Revenue Forecast (2018-2025)
        12.1.1 Global Opioid-induced Constipation Capacity, Production and Growth Rate Forecast (2018-2025)
        12.1.2 Global Opioid-induced Constipation Revenue and Growth Rate Forecast (2018-2025)
        12.1.3 Global Opioid-induced Constipation Price and Trend Forecast (2018-2025)
    12.2 Global Opioid-induced Constipation Production, Consumption , Import and Export Forecast by Region (2018-2025)
        12.2.1 North America Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.2 Europe Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.3 China Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.4 Japan Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.5 Southeast Asia Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        12.2.6 India Opioid-induced Constipation Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.3 Global Opioid-induced Constipation Production, Revenue and Price Forecast by Type (2018-2025)
    12.4 Global Opioid-induced Constipation Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer

List of Tables and Figures

    Figure Picture of Opioid-induced Constipation
    Figure Global Opioid-induced Constipation Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Opioid-induced Constipation Production Market Share by Types (Product Category) in 2017
    Figure Product Picture of Solid
    Table Major Manufacturers of Solid
    Figure Product Picture of Liquid
    Table Major Manufacturers of Liquid
    Figure Global Opioid-induced Constipation Consumption (K Units) by Applications (2013-2025)
    Figure Drugstore Examples
    Table Key Downstream Customer in Drugstore
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Global Opioid-induced Constipation Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
    Figure North America Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Opioid-induced Constipation Revenue (Million USD) Status and Outlook (2013-2025)
    Figure Global Opioid-induced Constipation Capacity, Production (K Units) Status and Outlook (2013-2025)
    Figure Global Opioid-induced Constipation Major Players Product Capacity (K Units) (2013-2018)
    Table Global Opioid-induced Constipation Capacity (K Units) of Key Manufacturers (2013-2018)
    Table Global Opioid-induced Constipation Capacity Market Share of Key Manufacturers (2013-2018)
    Figure Global Opioid-induced Constipation Capacity (K Units) of Key Manufacturers in 2017
    Figure Global Opioid-induced Constipation Capacity (K Units) of Key Manufacturers in 2018
    Figure Global Opioid-induced Constipation Major Players Product Production (K Units) (2013-2018)
    Table Global Opioid-induced Constipation Production (K Units) of Key Manufacturers (2013-2018)
    Table Global Opioid-induced Constipation Production Share by Manufacturers (2013-2018)
    Figure 2017 Opioid-induced Constipation Production Share by Manufacturers
    Figure 2017 Opioid-induced Constipation Production Share by Manufacturers
    Figure Global Opioid-induced Constipation Major Players Product Revenue (Million USD) (2013-2018)
    Table Global Opioid-induced Constipation Revenue (Million USD) by Manufacturers (2013-2018)
    Table Global Opioid-induced Constipation Revenue Share by Manufacturers (2013-2018)
    Table 2017 Global Opioid-induced Constipation Revenue Share by Manufacturers
    Table 2018 Global Opioid-induced Constipation Revenue Share by Manufacturers
    Table Global Market Opioid-induced Constipation Average Price (USD/Unit) of Key Manufacturers (2013-2018)
    Figure Global Market Opioid-induced Constipation Average Price (USD/Unit) of Key Manufacturers in 2017
    Table Manufacturers Opioid-induced Constipation Manufacturing Base Distribution and Sales Area
    Table Manufacturers Opioid-induced Constipation Product Category
    Figure Opioid-induced Constipation Market Share of Top 3 Manufacturers
    Figure Opioid-induced Constipation Market Share of Top 5 Manufacturers
    Table Global Opioid-induced Constipation Capacity (K Units) by Region (2013-2018)
    Figure Global Opioid-induced Constipation Capacity Market Share by Region (2013-2018)
    Figure Global Opioid-induced Constipation Capacity Market Share by Region (2013-2018)
    Figure 2017 Global Opioid-induced Constipation Capacity Market Share by Region
    Table Global Opioid-induced Constipation Production by Region (2013-2018)
    Figure Global Opioid-induced Constipation Production (K Units) by Region (2013-2018)
    Figure Global Opioid-induced Constipation Production Market Share by Region (2013-2018)
    Figure 2017 Global Opioid-induced Constipation Production Market Share by Region
    Table Global Opioid-induced Constipation Revenue (Million USD) by Region (2013-2018)
    Table Global Opioid-induced Constipation Revenue Market Share by Region (2013-2018)
    Figure Global Opioid-induced Constipation Revenue Market Share by Region (2013-2018)
    Table 2017 Global Opioid-induced Constipation Revenue Market Share by Region
    Figure Global Opioid-induced Constipation Capacity, Production (K Units) and Growth Rate (2013-2018)
    Table Global Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table North America Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Europe Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table China Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Japan Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Southeast Asia Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table India Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Table Global Opioid-induced Constipation Consumption (K Units) Market by Region (2013-2018)
    Table Global Opioid-induced Constipation Consumption Market Share by Region (2013-2018)
    Figure Global Opioid-induced Constipation Consumption Market Share by Region (2013-2018)
    Figure 2017 Global Opioid-induced Constipation Consumption (K Units) Market Share by Region
    Table North America Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Europe Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
    Table China Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Japan Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Southeast Asia Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
    Table India Opioid-induced Constipation Production, Consumption, Import & Export (K Units) (2013-2018)
    Table Global Opioid-induced Constipation Production (K Units) by Type (2013-2018)
    Table Global Opioid-induced Constipation Production Share by Type (2013-2018)
    Figure Production Market Share of Opioid-induced Constipation by Type (2013-2018)
    Figure 2017 Production Market Share of Opioid-induced Constipation by Type
    Table Global Opioid-induced Constipation Revenue (Million USD) by Type (2013-2018)
    Table Global Opioid-induced Constipation Revenue Share by Type (2013-2018)
    Figure Production Revenue Share of Opioid-induced Constipation by Type (2013-2018)
    Figure 2017 Revenue Market Share of Opioid-induced Constipation by Type
    Table Global Opioid-induced Constipation Price (USD/Unit) by Type (2013-2018)
    Figure Global Opioid-induced Constipation Production Growth by Type (2013-2018)
    Table Global Opioid-induced Constipation Consumption (K Units) by Application (2013-2018)
    Table Global Opioid-induced Constipation Consumption Market Share by Application (2013-2018)
    Figure Global Opioid-induced Constipation Consumption Market Share by Applications (2013-2018)
    Figure Global Opioid-induced Constipation Consumption Market Share by Application in 2017
    Table Global Opioid-induced Constipation Consumption Growth Rate by Application (2013-2018)
    Figure Global Opioid-induced Constipation Consumption Growth Rate by Application (2013-2018)
    Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table AstraZeneca Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure AstraZeneca Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure AstraZeneca Opioid-induced Constipation Production Market Share (2013-2018)
    Figure AstraZeneca Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Takeda Pharmaceutical Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Takeda Pharmaceutical Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Takeda Pharmaceutical Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Takeda Pharmaceutical Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Valeant Pharmaceuticals International Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Valeant Pharmaceuticals International Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Valeant Pharmaceuticals International Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Valeant Pharmaceuticals International Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Abbott Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Abbott Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Abbott Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Abbott Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bayer Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Bayer Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Bayer Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Bayer Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Boehringer Ingelheim Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Boehringer Ingelheim Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Boehringer Ingelheim Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Boehringer Ingelheim Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table C.B. Fleet Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table C.B. Fleet Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure C.B. Fleet Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure C.B. Fleet Opioid-induced Constipation Production Market Share (2013-2018)
    Figure C.B. Fleet Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Cosmo Pharmaceuticals Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Cosmo Pharmaceuticals Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Cosmo Pharmaceuticals Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Cosmo Pharmaceuticals Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Daewoong Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Daewoong Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Daewoong Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Daewoong Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Daewoong Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Daiichi Sankyo Opioid-induced Constipation Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Daiichi Sankyo Opioid-induced Constipation Production Growth Rate (2013-2018)
    Figure Daiichi Sankyo Opioid-induced Constipation Production Market Share (2013-2018)
    Figure Daiichi Sankyo Opioid-induced Constipation Revenue Market Share (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Opioid-induced Constipation
    Figure Manufacturing Process Analysis of Opioid-induced Constipation
    Figure Opioid-induced Constipation Industrial Chain Analysis
    Table Raw Materials Sources of Opioid-induced Constipation Major Manufacturers in 2017
    Table Major Buyers of Opioid-induced Constipation
    Table Distributors/Traders List
    Figure Global Opioid-induced Constipation Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Opioid-induced Constipation Price (Million USD) and Trend Forecast (2018-2025)
    Table Global Opioid-induced Constipation Production (K Units) Forecast by Region (2018-2025)
    Figure Global Opioid-induced Constipation Production Market Share Forecast by Region (2018-2025)
    Table Global Opioid-induced Constipation Consumption (K Units) Forecast by Region (2018-2025)
    Figure Global Opioid-induced Constipation Consumption Market Share Forecast by Region (2018-2025)
    Figure North America Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure North America Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table North America Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Asia-Pacific Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Asia-Pacific Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Asia-Pacific Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Europe Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Europe Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Central & South America Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Central & South America Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Central & South America Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure Southeast Asia Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Southeast Asia Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Figure India Opioid-induced Constipation Production (K Units) and Growth Rate Forecast (2018-2025)
    Figure India Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table India Opioid-induced Constipation Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
    Table Global Opioid-induced Constipation Production (K Units) Forecast by Type (2018-2025)
    Figure Global Opioid-induced Constipation Production (K Units) Forecast by Type (2018-2025)
    Table Global Opioid-induced Constipation Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Opioid-induced Constipation Revenue Market Share Forecast by Type (2018-2025)
    Table Global Opioid-induced Constipation Price Forecast by Type (2018-2025)
    Table Global Opioid-induced Constipation Consumption (K Units) Forecast by Application (2018-2025)
    Figure Global Opioid-induced Constipation Consumption (K Units) Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Source

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.